4 Results for "

coronary tissues

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "coronary tissues" in MCE Product Catalog:

Cat. No.: HY-P1636
CAS No.: 113274-56-9
Research Areas:  

Metabolic Disease

Hirudin (54-65) is a thrombin antagonist and YAP suppressor with anticoagulatory properties.Hirudin (54-65) blocks thrombin's anion binding site, acts on soluble and thrombus-bound thrombin.Hirudin (54-65) suppresses thrombin-induced profibrotic YAP activity, reduces YAP expression, nuclear translocation, and downstream effector signaling in vascular endothelial cells.Hirudin (54-65) ameliorates obstructive cholestasis, attenuates liver fibrosis symptoms, fibrosis-associated angiogenesis, and endothelial-to-mesenchymal transition.Hirudin (54-65) reduces liver inflammation and tissue hypoxia.Hirudin (54-65) promotes extracellular calcium influx through L-type calcium channels in canine coronary artery smooth muscle, mediates contraction.Hirudin (54-65) induces endothelium-independent contraction of canine coronary arterial segments; this response is not affected by indomethacin pretreatment.Hirudin (54-65) can be used for the research of liver obstructive cholestasis, liver fibrosis .
loading...
    loading...
Cat. No.: HY-N6066
CAS No.: 78478-28-1
Praeruptorin E is an orally active pyranocoumarin compound. Praeruptorin E can be isolated from the dried roots of Peucedanum praeruptorum Dunn. Praeruptorin E reduces the expression of NF-κB. Praeruptorin E upregulates the expression of PXR and CYP3A4. Praeruptorin E inhibits Th2 cytokines, TNF-α, IL6, MPO, and blocks the Ca 2+ slow channel. Praeruptorin E promotes pulmonary tissue repair and relaxes porcine coronary artery strips. Praeruptorin E protects mice from lipopolysaccharide- and hydrochloric acid-induced acute lung injury. Praeruptorin E can be used in studies related to asthma and acute lung injury .
loading...
    loading...
Cat. No.: HY-117200
CAS No.: 351062-08-3
Purity:  ≥98.0%
Synonyms: Nec-7
Necrostatin-7 (Nec-7) is a Necroptosis inhibitor with an EC50 of 10.6 μM. Necrostatin-7 inhibits signal transduction from RANK to NFATc1 without affecting the activation of MAPK or NF-κB. Necrostatin-7 suppresses the expression levels of Acp5, Atp6v0d2, Ctsk and Dcstamp. Necrostatin-7 reduces myocardial infarction size, ameliorates adverse left ventricular remodeling, decreases myocardial wall stress, reduces the amount and length of scar tissue, and improves left ventricular function. Necrostatin-7 exerts cardioprotective effects in a rat model of permanent coronary artery occlusion. Necrostatin-7 can be used in research related to osteolytic bone diseases and myocardial infarction .
loading...
    loading...
Cat. No.: HY-137718
CAS No.: 3545-76-4
Synonyms: cIMP
Inosine 3',5'-cyclic monophosphate (cIMP) is an endogenous cyclic nucleotide second messenger molecule generated by guanylate cyclase (sGC) that mediates vasoconstrictive responses in vascular tissue. Inosine 3',5'-cyclic monophosphate-mediated vasoconstrictive effects depend on an intact eNOS‑NO‑sGC signaling axis, and PDE5 and PDE4A mediate enhanced metabolism of cGMP and cAMP, thereby relieving the masking of the vasoconstrictive activity of cIMP. Inosine 3',5'-cyclic monophosphate participates in the regulation of vascular tone homeostasis and the signaling process of hypoxia-induced coronary vasospasm. Inosine 3',5'-cyclic monophosphate can be used for mechanistic studies of vascular homeostasis and hypoxic coronary vasospasm .
loading...
    loading...